{
  "id": 5494279,
  "title": "Off-Label GLP-1 Use Skyrockets in Young Kids",
  "url": "https://urgent.news/2026/09/04/off-label-glp-1-use-skyrockets-in-young-kids",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-04T04:01:00.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/pediatrics/obesity/122883"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- Prescribing GLP-1 receptor agonists to children ages 8 to 11 years with obesity surged 310-fold since 2019, despite a lack of FDA approval in kids under 12, a large cross-sectional analysis showed. Among over 3.5 million children...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}